“Oral … of BBR inhibited the NF-κB signal transduction pathway, reduced the expression of pro-inflammatory cytokines [interleukin (IL)-…, IL-6, interferon-γ, and tumor necrosis factor-α], promoted the expression of anti-inflammatory cytokines ( IL-10 and transforming growth factor-β), and improved the terminal ileum tissue inflammation.”